Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer

Abstract Background Colorectal cancer (CRC) is the most common digestive cancer in the world. Microsatellite stability (MSS) and microsatellite instability (MSI-high) are important molecular subtypes of CRC closely related to tumor occurrence and progression and immunotherapy efficacy. The presence...

Full description

Saved in:
Bibliographic Details
Main Authors: Fangze Wei, Xiaotian Xu, Jing Wang, Shi Wen Mei, Fu Qiang Zhao, Fei Huang, Ti Xian Xiao, Guo Jing Wang, Baojun Wei, Shengkai Huang, Wei Cui
Format: Article
Language:English
Published: Springer 2024-12-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-024-03887-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571633749983232
author Fangze Wei
Xiaotian Xu
Jing Wang
Shi Wen Mei
Fu Qiang Zhao
Fei Huang
Ti Xian Xiao
Guo Jing Wang
Baojun Wei
Shengkai Huang
Wei Cui
author_facet Fangze Wei
Xiaotian Xu
Jing Wang
Shi Wen Mei
Fu Qiang Zhao
Fei Huang
Ti Xian Xiao
Guo Jing Wang
Baojun Wei
Shengkai Huang
Wei Cui
author_sort Fangze Wei
collection DOAJ
description Abstract Background Colorectal cancer (CRC) is the most common digestive cancer in the world. Microsatellite stability (MSS) and microsatellite instability (MSI-high) are important molecular subtypes of CRC closely related to tumor occurrence and progression and immunotherapy efficacy. The presence of CD8+ CXCR5+ follicular cytotoxic T (TFC) cells is strongly associated with autoimmune disease and CD8+ effector function. However, the roles of TFC cells in MSI-high CRC and MSS CRC are unclear. Here, we aimed to explore the characteristics of TFC cells in CRC and compare their biological functions between MSI-high and MSS CRC. Methods We explored the expression of TFC cell in tumor tissues and peripheral blood in our clinical cohort and public datasets. By combining single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing, we explored the potential function of TFC cells and developed a prediction model for CRC. We also compared the biological functions of these cells between MSS and MSI-high CRC and used flow cytometry and coculture experiments to explore their potential regulatory functions. Results TFC cell markers are downregulated in tumor tissues and patient peripheral blood vs. controls. The prediction model for CRC performed well in the training and validation cohorts (KM plot p < 0.001). MSS CRC patients exhibit enrichment of genes related to the cell cycle (MKI67) and T cell activation (CD38 and HLA-DR) and decreased enrichment of immune checkpoint markers (PD1, TIM3, and LAG3). The expression of TFC cell-related genes is positively correlated with that of CD8+IFN-γ+-related genes and closely related to that of TLS-related genes in MSS CRC. The proportion of TFC cells is positively correlated with that of CD19+CD38+ B cells in MSS CRC. Conclusions The prognostic prediction model has good predictive value. In MSS CRC, TFC cells function mostly in T cell activation and the cell cycle and have low expression of immune checkpoint molecules, which may influence the effectiveness of ICB therapy. TFC cells may regulate antitumor function by regulating CD19+ CD38+ B cells and TLSs.
format Article
id doaj-art-16268760be154a2499cdebd9363f085d
institution Kabale University
issn 1432-0851
language English
publishDate 2024-12-01
publisher Springer
record_format Article
series Cancer Immunology, Immunotherapy
spelling doaj-art-16268760be154a2499cdebd9363f085d2025-02-02T12:26:45ZengSpringerCancer Immunology, Immunotherapy1432-08512024-12-0174111410.1007/s00262-024-03887-zIntratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancerFangze Wei0Xiaotian Xu1Jing Wang2Shi Wen Mei3Fu Qiang Zhao4Fei Huang5Ti Xian Xiao6Guo Jing Wang7Baojun Wei8Shengkai Huang9Wei Cui10Department of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Clinical Laboratory, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Background Colorectal cancer (CRC) is the most common digestive cancer in the world. Microsatellite stability (MSS) and microsatellite instability (MSI-high) are important molecular subtypes of CRC closely related to tumor occurrence and progression and immunotherapy efficacy. The presence of CD8+ CXCR5+ follicular cytotoxic T (TFC) cells is strongly associated with autoimmune disease and CD8+ effector function. However, the roles of TFC cells in MSI-high CRC and MSS CRC are unclear. Here, we aimed to explore the characteristics of TFC cells in CRC and compare their biological functions between MSI-high and MSS CRC. Methods We explored the expression of TFC cell in tumor tissues and peripheral blood in our clinical cohort and public datasets. By combining single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing, we explored the potential function of TFC cells and developed a prediction model for CRC. We also compared the biological functions of these cells between MSS and MSI-high CRC and used flow cytometry and coculture experiments to explore their potential regulatory functions. Results TFC cell markers are downregulated in tumor tissues and patient peripheral blood vs. controls. The prediction model for CRC performed well in the training and validation cohorts (KM plot p < 0.001). MSS CRC patients exhibit enrichment of genes related to the cell cycle (MKI67) and T cell activation (CD38 and HLA-DR) and decreased enrichment of immune checkpoint markers (PD1, TIM3, and LAG3). The expression of TFC cell-related genes is positively correlated with that of CD8+IFN-γ+-related genes and closely related to that of TLS-related genes in MSS CRC. The proportion of TFC cells is positively correlated with that of CD19+CD38+ B cells in MSS CRC. Conclusions The prognostic prediction model has good predictive value. In MSS CRC, TFC cells function mostly in T cell activation and the cell cycle and have low expression of immune checkpoint molecules, which may influence the effectiveness of ICB therapy. TFC cells may regulate antitumor function by regulating CD19+ CD38+ B cells and TLSs.https://doi.org/10.1007/s00262-024-03887-zTFCColorectal cancerscRNA-seqMachine learning model
spellingShingle Fangze Wei
Xiaotian Xu
Jing Wang
Shi Wen Mei
Fu Qiang Zhao
Fei Huang
Ti Xian Xiao
Guo Jing Wang
Baojun Wei
Shengkai Huang
Wei Cui
Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
Cancer Immunology, Immunotherapy
TFC
Colorectal cancer
scRNA-seq
Machine learning model
title Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
title_full Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
title_fullStr Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
title_full_unstemmed Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
title_short Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
title_sort intratumoural cd8 cxcr5 follicular cytotoxic t cells have prognostic value and are associated with cd19 cd38 b cells and tertiary lymphoid structures in colorectal cancer
topic TFC
Colorectal cancer
scRNA-seq
Machine learning model
url https://doi.org/10.1007/s00262-024-03887-z
work_keys_str_mv AT fangzewei intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT xiaotianxu intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT jingwang intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT shiwenmei intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT fuqiangzhao intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT feihuang intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT tixianxiao intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT guojingwang intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT baojunwei intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT shengkaihuang intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer
AT weicui intratumouralcd8cxcr5follicularcytotoxictcellshaveprognosticvalueandareassociatedwithcd19cd38bcellsandtertiarylymphoidstructuresincolorectalcancer